Track topics on Twitter Track topics that are important to you
Antibodies are increasingly becoming the preferred choice to treat several disorders such as respiratory diseases, oncology, and inflammatory diseases. The rising application of these antibodies in drug development increases revenue generation in the mAbs market, contributing to the overall market growth. Globally, technological enhancements and huge RD in genomic studies, continuous improvement and innovation in Monoclonal Antibodies technologies and growing population are the prime growth drivers of Monoclonal Antibodies market. In addition, Increase in adoption of Monoclonal Antibodies in emerging economies such as China, India and others, will create new opportunities for moloclonal antibodies market. However, higher cost of the research and development, and complex government approval processes are the key restraints for moloclonal antibodies market.
Globally, Asia Pacific will be the fastestgrowing region in the mAbs market and is likely to grow. Much of the region's growth can be attributed to the rising occurrence of diseases and healthcare investments provided by the respective governments and increased outofpocket expenditure by individuals. Moreover, the rising number of initiatives undertaken by major vendors to assist patients in the Asia Pacific countries and recent launches of new products are significant contributors to the high sales of sales mAbs in this region.
This report identifies the global Monoclonal Antibodies market size in for the year 20142016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global Monoclonal Antibodies market.
This report segments global Monoclonal Antibodies market on the basis of application, and regional market as follows:
Global Monoclonal Antibodies Market By Application: Oncology, Autoimmune and inflammatory diseases, Respiratory diseases and Ophthalmology and Others
This report has been further segmented into major regions, which include detailed analysis of each region such as: North America, Europe, AsiaPacific APAC, and Rest of the World RoW covering all the major country level markets in each of the region. The major countries considered under the AsiaPacific region are India, China, South Korea and Japan. The major countries considered under the European region are Germany, U.K., France, Italy, Spain and Russia. The major countries considered under the North American region are United States, Canada and Mexico
This report identifies all the major companies operating in the global Monoclonal Antibodies market. Some of the major companies' profiles in detail are as follows:
Original Article: Monoclonal Antibodies Market: By Application [Oncology, Autoimmune and inflammatory diseases, Respiratory diseases and Ophthalmology] By Geography Europe, Asia Pacific, North America, Rest of the WorldForecast 20162021 [Updated: 27012016] Prices from USDNEXT ARTICLE
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs. They're usually caused by viruses, but they can also ...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...